Skip to contentS
Sensus Healthcare, Inc.
S
SRTSSensus Healthcare, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$13.10M$13.10Mderived+0.6% vs Q4 2021 Net Income$2.83M$2.83Mderived−46.8% vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sensus Healthcare, Inc. · CIK 1494891 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$8,349,000−5.7% Operating Incomederived$4,170,000−21.6% Operating Cash Flowderived-$10,113,000N/M Free Cash Flowderived-$10,123,000N/M Margins · derivedGross margin63.7%−4.3 pt vs Q4 2021
Operating margin31.8%−9.0 pt vs Q4 2021
Net margin21.6%−19.2 pt vs Q4 2021
ended Dec 31, 2022 · filed Mar 23, 2023 · 82 d after period end